NABPH.AU's price fluctuates due to several factors. Company Performance: Positive clinical trial results or new product launches typically increase the stock price, while failures can decrease it.

Market Sentiment: Overall investor confidence in the biotechnology sector influences NABPH.AU's stock performance. Bullish markets lift the stock, while bearish ones depress it.

Regulatory Approvals: Approval or rejection of Nabriva's drugs by regulatory bodies like the FDA (if applicable outside Australia) significantly impacts the price.

Competition: The emergence of competing drugs or treatments for similar conditions can put downward pressure on Nabriva's stock price.

Macroeconomic Factors: Economic indicators like interest rates and inflation can influence investor behavior and thus affect stock prices.

News & Events: Major news related to the company, its competitors, or the industry in general can cause price volatility.

Analyst Ratings: Stock analysts' buy, hold, or sell recommendations can influence investors' decisions and stock price movements.

Financial Health: Nabriva Therapeutics' financial stability, including revenue, profitability, and debt levels, greatly impact investor confidence and the stock's value.